Effects of a preovulatory single low dose of mifepristone on ovarian function

European Journal of Contraception and Reproductive Health Care

Volumn 11, Issue 2, 2006, Pages 104-108

  Van Der Stege, Jolande G ^a   Pahl Van Beest, Elske H ^b   Beerthuizen, Rob J C M ^c   Van Lunsen, Rik H W ^d   Scholten, Piet C ^e   Bogchelman, Dick H ^b  

^a MEANDER MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Dutch Foundation for Contraception   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

Emergency contraception; Follicular growth; Mechanism of action; Mifepristone; Ovarian function; Ovulation

Indexed keywords

MIFEPRISTONE; PLACEBO; PROGESTERONE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; EMERGENCY CONTRACEPTION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; NORMAL HUMAN; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVULATION; OVULATION INHIBITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; ULTRASOUND; WILCOXON SIGNED RANKS TEST;

CONTRACEPTIVES, POSTCOITAL, SYNTHETIC; DOUBLE-BLIND METHOD; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEINIZING HORMONE; MIFEPRISTONE; OVARIAN FOLLICLE; OVULATION; STATISTICS, NONPARAMETRIC;

EID: 33749002859     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625180500539505     Document Type: Article

References (15)

1. von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002;360:1803-10.
2. Piaggio G, Heng Z, von Hertzen H, et al. Combined estimates of effectiveness of mifepristone 10 mg in emergency contraception. Contraception 2003;68:439-46.
3. Task Force on Post-ovulatory Methods of Fertility Regulation. Comparison of three single doses of mifepristone as emergency contraception: a randomized trial. Lancet 1999;353:697-702.
4. Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. Baltimore, MD: Williams & Wilkins, 1999;77.
5. Croxatto HB, Devoto L, Durand M, et al.Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature. Contraception 2001;63:111-21.
6. Shoupe D, Mishell DR, Page MA, et al. Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase. Am J Obstet Gynecol 1987;157:1421-6.
7. Swahn ML. Johannisson E, Daniore V, et al. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium. Hum Reprod 1988;3:915-21.
8. Wetzels LCG, Hoogland HJ. Relation between ultrasonographic evidence of ovulation and hormonal parameters: luteinizing hormone surge and initial progesterone rise. Fertil Steril 1982;37:336-41.
9. Queenan JT, O'Brien GD, Bains LM, et al. Ultrasound scanning of ovaries to detect ovulation in women. Fertil Steril 1980;34:99-105.
10. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. New Engl J Med 1995;333:1517-21.
11. Marions L, Hultenby K, Lindell I, et al. Emergency contraception with mifepristone and levonorgestrel: Mechanism of action. Obstet Gynecol 2002;100:65-71.
12. Couzinet B, Brailly S, Bouchard P, et al. Progesterone stimulates luteinizing hormone secretion by acting directly on the pituitary. J Clin Endocrinol Metab 1992;74:374-8.
13. Batista MC, Cartledge TP, Zellmer AW, et al. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation. J Clin Endocrinol Metab 1992;74:565-70.
14. Lydon JP, DeMayo FJ, Funk CR, et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995;18:2266-78.
15. Robker RL, Russell DL, Yoshioka S, et al. Ovulation: a multi-gene, multi-step process. Steroids 2000;65:559-70.